← All trials
NCT02066792
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Mar 1, 2018
- Completion date
- Mar 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 156
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- The University of Texas, DallasLead sponsor
- Boston UniversityOverall official - principal investigator
- Rush UniversityOverall official - principal investigator
- The University of Texas, DallasOverall official - principal investigator
- Boston UniversityCollaborator
- Southern Methodist UniversityCollaborator
- Rush UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.